Quoin Pharmaceuticals Ltd banner

Intrinsic Value

QNRX doesn't have a meaningful market cap.

The intrinsic value of Quoin Pharmaceuticals Ltd (QNRX) under the Base Case is USD per share. Compared with the current market price of 3.56 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

QNRX Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when QNRX is below its intrinsic value
Today Hidden ·
QNRX Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to QNRX

Fundamental Analysis

What Quoin Pharmaceuticals Does

Biotechnology Health Care

Quoin Pharmaceuticals is a biopharmaceutical company focused on rare genetic skin diseases. It develops prescription treatments for conditions that have few or no approved therapies, with programs aimed at disorders such as Netherton syndrome and other severe dermatology diseases. The company’s work is centered on turning drug candidates into medicines that doctors can prescribe to patients with these hard-to-treat conditions.

Headquarters
Israel IL
Employees
4
IPO date
Nov 1, 1989
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Quoin Pharmaceuticals insiders are buying within their usual range

Insider trading · Last trade on Aug 31, 2026

Sold $0 Nobody sold
Bought $280k 4 insiders
Trades by date
Open insider trading

Continue QNRX Research

Decided on Quoin Pharmaceuticals? Get an email when QNRX reaches the price you’d buy at. Free with an account.

Other Quoin Pharmaceuticals listings

What is the Intrinsic Value of one QNRX stock?

The intrinsic value for Quoin Pharmaceuticals Ltd (QNRX) under the Base Case is USD.

Is QNRX stock undervalued or overvalued?

Compared with the current market price of 3.56 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top